In addition to these
offices, Thermo Fisher
Scientific maintains
a network of represen-
tative organizations
throughout the world.
Africa
+43 1 333 5034 127
Australia
+61 2 8844 9500
Austria
+43 1 333 50340
Belgium
+32 2 482 30 30
Canada
+1 800 530 8447
China
+86 10 5850 3588
Denmark
+45 70 23 62 60
Europe-Other
+43 1 333 5034 127
France
+33 1 60 92 48 00
Germany
+49 6103 408 1014
India
+91 22 6742 9434
Italy
+39 02 950 591
Japan
+81 45 453 9100
Latin America
+1 608 276 5659
Middle East
+43 1 333 5034 127
Netherlands
+31 76 587 98 88
South Africa
+27 11 570 1840
Spain
+34 914 845 965
Sweden/Norway/
Finland
+46 8 556 468 00
Switzerland
+41 61 48784 00
UK
+44 1442 233555
USA
+1 800 532 4752
www.thermo.comAN62561E 12/07S
Part of Thermo Fisher Scientific
Thermo Fisher Scientific,
San Jose, CA USA is ISO Certified.
Legal Notices
©2007 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries. This information
is presented as an example of the capabilities of Thermo Fisher Scientific Inc. products. It is not intended to encourage use of these products in any manners
that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all
countries. Please consult your local sales representative for details.
View additional Thermo Scientific LC/MS application notes at:
www.thermo.com/appnotesThe increase in selectivity at a peak width setting
of 0.1 Da FWHM is due to the fact that Clenbuterol
is a chlorinated compound and thus the negative mass
deficiency can be used to eliminate interferents from the
urine matrix in SRM mode. This increased selectivity can
be achieved without detrimental loss of transmission.
Typically only a factor of two to three fold decrease in
peak area is observed between analyses performed at 0.7
and 0.1 Da FWHM, however, greater selectivity could
then be achieved.
The calibration curves for Clenbuterol concentrations
of between 0.1 to 100 pg/µL at resolution settings of 0.1
and 0.7 Da FWHM both demonstrate excellent linearity.
The calibration line at 0.7 Da FWHM showed a high
intercept due to chemical background in the urine blank.
This was significantly reduced by the use of high
resolution.
The use of higher resolution to increase selectivity
and precision could enable the limit of quantitation
of an assay to be lowered and achieves a higher degree
of confidence in identification of analytes in biological
matrices.
Table 2: Calculated standards at 0.1 Da FWHM
SAMPLE NAME AREA
CALC AMT UNITS %RSD
Urine blank
0.00
0.00
pg/L
Urine blank
0.00
0.00
pg/L
Cal 0.1 pg/L
11245.02
0.10
pg/L
0.2%
Cal 0.1 pg/L
11272.54
0.10
pg/L
0.2%
Cal 0.5 pg/L
41960.02
0.46
pg/L
1.1%
Cal 0.5 pg/L
42592.84
0.46
pg/L
1.1%
Cal 1 pg/L
90353.60
1.02
pg/L
3.4%
Cal 1 pg/L
94633.92
1.07
pg/L
3.4%
Cal 5 pg/L
435920.49
5.04
pg/L
0.4%
Cal 5 pg/L
438538.32
5.07
pg/L
0.4%
Cal 10 pg/L
893656.24
10.36
pg/L
0.9%
Cal 10 pg/L
904758.00
10.49
pg/L
0.9%
Cal 50 pg/L
4120496.02
47.90
pg/L
1.3%
Cal 50 pg/L
4195902.58
48.78
pg/L
.3%
Cal 100 pg/L
8667429.70
100.81
pg/L
0.5%
Cal 100 pg/L
8727427.54
101.50
pg/L
0.5%